Ams Osram Balances a Pending Antitrust Decision with an Ambitious AI Photonics Push
Published on 06/24/2026 at 19:13 | Redaktion boerse-global.de
The Asian chip rout that rocked semiconductor stocks on Tuesday briefly knocked Ams Osram shares almost nine percent lower, but the battered stock has since clawed back above €20. The rebound — 1.75 percent higher at €20.30 in recent trading — masks a reality that any holder of this name knows intimately: extreme volatility. The annualised 30-day reading sits at 95.51 percent, and over the past month the shares have shed roughly 22 percent. Yet on a year-to-date basis the rally remains spectacular, with gains approaching 139 percent.
That whipsaw behaviour reflects the peculiar position Ams Osram occupies. It is a company in the midst of a sweeping balance-sheet overhaul, one that depends on a single regulatory green light for its next leg, while simultaneously planting a flag in the nascent AI-infrastructure market. The immediate catalyst is in Bonn. The Bundeskartellamt has been reviewing the €570 million cash sale of the company’s non-optical sensor business to Infineon since 3 March 2026, with a decision promised before the current quarter closes. Approval would slash net leverage from 3.3 times to around 2.5 times, offering a direct line to cheaper financing and a cleaner capital structure.
Behind the headline deal lies a broader refinancing push. Ams Osram has placed a €1 billion bond carrying a 7.25 percent coupon and maturing in May 2032, using the proceeds to retire older, far more expensive paper — a 12.25 percent USD note in full and a 10.5 percent euro tranche partially. The move will shave roughly €40 million in annual interest costs from 2027 onward. Add to that a pipeline of smaller divestitures, including the sale of the CMOS image sensor unit to indie Semiconductor for €40 million, and the group expects total disposal proceeds of about €670 million.
Should investors sell immediately? Or is it worth buying Ams Osram?
One stubborn liability remains: the empty factory in Kulim, Malaysia. Built to serve a client that later cancelled the project, the facility now costs the company a double-digit million sum each year. Leasing it out could remove roughly €400 million in long-term obligations from the books — a hidden upside that analysts often flag but management has yet to secure.
Operationally, the first quarter of 2026 offered a solid base. Revenue came in at €796 million, at the top end of the company’s own guidance, while the adjusted EBITDA margin hit 16.5 percent. Free cash flow turned positive to €37 million, reversing a €28 million outflow in the prior-year period. For the full year, management targets free cash flow above €300 million, helped by those divestment proceeds.
Beyond the near-term cleanup, the longer story is about photonics. Ams Osram has signed a development agreement with a leading partner in the AI infrastructure space to build micro-emitter arrays — essentially, high-speed optical links for data centres. Initially the focus is on interconnects between server racks; eventually the ambition stretches to chip-to-chip communication. Chief Financial Officer Rainer Irle has described the revenue potential as a “high triple-digit million” opportunity, but significant inflows are not expected before 2030. Until then, the project remains a pure R&D bet.
For all the talk of a strategic pivot, the next concrete test for investors is not a photonics breakthrough — it is the Bundeskartellamt’s verdict. A positive outcome would validate the restructuring roadmap and allow management to focus on selling the Kulim facility and nurturing the AI pipeline. A red light would leave net debt above €1 billion as the dominant overhang. The shares have already priced in plenty of turbulence; the regulator’s answer will determine whether the turbulence becomes a tailwind.
Ad
Ams Osram Stock: New Analysis - 24 June
Fresh Ams Osram information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
